Free Trial

Provectus Biopharmaceuticals (PVCT) Short Interest Ratio & Short Volume

$0.19
0.00 (0.00%)
(As of 05/21/2024 ET)

Provectus Biopharmaceuticals Short Interest Data

Current Short Interest
142,600 shares
Previous Short Interest
62,600 shares
Change Vs. Previous Month
+127.80%
Dollar Volume Sold Short
$28,377.40
Short Interest Ratio
0.4 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
419,520,000 shares
Percentage of Shares Shorted
0.03%
Today's Trading Volume
186,972 shares
Average Trading Volume
155,262 shares
Today's Volume Vs. Average
120%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Provectus Biopharmaceuticals ?

Sign up to receive the latest short interest report for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PVCT Short Interest Over Time

PVCT Days to Cover Over Time

PVCT Percentage of Float Shorted Over Time

Provectus Biopharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024142,600 shares $28,377.40 +127.8%N/A0.4 $0.20
4/15/202462,600 shares $10,485.50 -67.2%N/A0.1 $0.17
3/31/2024190,800 shares $34,887.78 +1,700.0%N/A0.3 $0.18
3/15/202410,600 shares $2,299.14 -85.7%N/A0 $0.22
2/29/202474,000 shares $11,003.80 -4.0%N/A0.2 $0.15
2/15/202477,100 shares $10,470.18 +1,780.5%N/A0.2 $0.14
1/15/202416,300 shares $1,677.27 -50.6%N/A0.1 $0.10
12/31/202333,000 shares $3,168.00 +89.7%N/A0.1 $0.10
12/15/202317,400 shares $1,896.60 +3.0%N/A0 $0.11
11/30/202316,900 shares $2,535.00 -46.5%N/A0 $0.15
11/15/202331,600 shares $4,740.00 +179.7%N/A0 $0.15
10/31/202311,300 shares $904.00 +2,160.0%N/A0 $0.08
10/15/2023500 shares $35.00 No ChangeN/A0 $0.07
9/30/2023500 shares $42.25 -94.8%N/A0 $0.08
9/15/20239,600 shares $943.68 +100.0%N/A0.1 $0.10
8/31/20234,800 shares $489.60 -46.1%N/A0 $0.10
8/15/20238,900 shares $845.50 +1,680.0%N/A0 $0.10
7/31/2023500 shares $54.45 -97.8%N/A0 $0.11
7/15/202322,300 shares $2,796.42 -64.6%N/A0.1 $0.13
6/30/202363,000 shares $7,125.30 +63.6%N/A0.1 $0.11
6/15/202338,500 shares $4,581.50 +7,600.0%N/A0.1 $0.12
5/31/2023500 shares $67.95 -99.4%N/A0 $0.14
5/15/202381,400 shares $11,387.86 +13,466.7%N/A0.4 $0.14
4/30/2023600 shares $80.22 -81.3%N/A0 $0.13
4/15/20233,200 shares $489.60 -96.4%N/A0 $0.15
3/31/202389,000 shares $14,685.00 +88,900.0%N/A0.3 $0.17
3/15/2023100 shares $15.40 -99.9%N/A0 $0.15
2/28/2023116,600 shares $18,772.60 +3,051.4%N/A0.3 $0.16
2/15/20233,700 shares $395.53 -89.5%N/A0 $0.11
1/31/202335,200 shares $4,509.12 +262.9%N/A0.1 $0.13
1/15/20239,700 shares $1,286.71 +9,600.0%N/A0 $0.13
12/30/2022100 shares $10.83 -99.0%N/A0 $0.11
12/15/202210,000 shares $1,099.00 -66.6%N/A0 $0.11
11/30/202229,900 shares $2,780.70 -45.5%N/A0 $0.09
11/15/202254,900 shares $2,843.82 +54,800.0%N/A0.1 $0.05
10/31/2022100 shares $5.00 No ChangeN/A0 $0.05
10/15/2022100 shares $4.85 No ChangeN/A0 $0.05
9/30/2022100 shares $4.90 -99.6%N/A0 $0.05
9/15/202225,500 shares $1,351.50 +8.5%N/A0.1 $0.05
8/31/202223,500 shares $1,280.75 +2,511.1%N/A0.1 $0.05
Elon to Transform U.S. Economy? (Ad)

Elon Musk has publicly called for the adoption of a controversial technology that the global establishment has been trying to suppress for decades. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here now to watch my new exposé.
8/15/2022900 shares $49.50 +80.0%N/A0 $0.06
7/31/2022500 shares $29.00 +400.0%N/A0 $0.06
7/15/2022100 shares $5.99 -99.6%N/A0 $0.06
6/30/202226,200 shares $1,419.28 +26,100.0%N/A0.1 $0.05
6/15/2022100 shares $5.30 -96.8%N/A0 $0.05
5/31/20223,100 shares $186.00 -54.4%N/A0 $0.06
5/15/20226,800 shares $357.68 +3,300.0%N/A0 $0.05
4/30/2022200 shares $12.28 +100.0%N/A0 $0.06
4/15/2022100 shares $5.86 No ChangeN/A0 $0.06
3/31/2022100 shares $6.74 No ChangeN/A0 $0.07
3/15/2022100 shares $6.92 -96.7%N/A0 $0.07
2/28/20223,000 shares $206.70 +2,900.0%N/A0 $0.07
2/15/2022100 shares $7.00 -98.7%N/A0 $0.07
1/31/20227,700 shares $500.50 -85.4%N/A0 $0.07
1/15/202252,600 shares $3,682.00 +39.2%N/A0.1 $0.07
12/31/202137,800 shares $2,079.00 +37,700.0%N/A0 $0.06
12/15/2021100 shares $5.03 -93.8%N/A0 $0.05
11/30/20211,600 shares $85.76 -61.0%N/A0 $0.05
11/15/20214,100 shares $213.61 +4,000.0%N/A0 $0.05
10/29/2021100 shares $5.62 -99.9%N/A0 $0.06
10/15/202190,700 shares $5,587.12 -24.6%N/A0.4 $0.06
9/30/2021120,300 shares $7,819.50 +55.8%N/A0.3 $0.07
9/15/202177,200 shares $4,863.60 -45.4%N/A0.2 $0.06
8/31/2021141,300 shares $8,619.30 -29.4%N/A0.1 $0.06
8/13/2021200,200 shares $13,913.90 -22.3%N/A0.5 $0.07
7/30/2021257,500 shares $17,896.25 +29.7%N/A1 $0.07
7/15/2021198,600 shares $13,902.00 +13.6%N/A0.4 $0.07
6/30/2021174,900 shares $11,980.65 -3.6%N/A0.7 $0.07
6/15/2021181,500 shares $12,668.70 -10.4%N/A0.3 $0.07
5/28/2021202,600 shares $14,911.36 +9.0%N/A0.5 $0.07
5/14/2021185,800 shares $12,430.02 +16.1%N/A0.6 $0.07
4/30/2021160,000 shares $10,400.00 No ChangeN/A0.3 $0.07
4/15/2021160,000 shares $10,752.00 -14.5%N/A0.5 $0.07
3/31/2021187,200 shares $13,122.72 +10.1%N/A0.3 $0.07
3/15/2021170,000 shares $11,645.00 +6.3%N/A0.5 $0.07
2/26/2021160,000 shares $11,680.00 -34.0%N/A0.3 $0.07
2/12/2021242,400 shares $17,695.20 +25.9%N/A0.3 $0.07
1/29/2021192,600 shares $14,445.00 -54.3%N/A0.1 $0.08
1/15/2021299,400 shares $20,898.12 +76.1%N/A0.4 $0.07
12/31/2020160,500 shares $9,292.95 -46.4%N/A0.3 $0.06
12/15/2020299,400 shares $17,514.90 +76.1%N/A0.4 $0.06
11/30/2020170,000 shares $10,880.00 -1.4%N/A0.3 $0.06
11/15/2020172,400 shares $11,585.28 -46.8%N/A0.6 $0.07
10/30/2020324,100 shares $22,038.80 +23.8%N/A0.9 $0.07
10/15/2020261,700 shares $19,889.20 -44.8%N/A0.5 $0.08
9/30/2020473,700 shares $41,022.42 +194.6%N/A0.7 $0.09
9/15/2020160,800 shares $11,674.08 +0.2%N/A0.4 $0.07
8/31/2020160,500 shares $12,968.40 -42.0%N/A0.3 $0.08
8/14/2020276,700 shares $26,148.15 +3,493.5%N/A0.2 $0.09
7/31/20207,700 shares $553.63 -67.4%N/A0 $0.07
Elon to Transform U.S. Economy? (Ad)

Elon Musk has publicly called for the adoption of a controversial technology that the global establishment has been trying to suppress for decades. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here now to watch my new exposé.
7/15/202023,600 shares $1,413.64 +81.5%N/A0.1 $0.06
6/30/202013,000 shares $585.00 +20.4%N/A0 $0.05
6/15/202010,800 shares $509.76 +2,060.0%N/A0 $0.05
5/29/2020500 shares $22.30 -80.0%N/A0 $0.04
5/15/20202,500 shares $105.25 +400.0%N/A0 $0.04
4/30/2020500 shares $21.00 No ChangeN/A0 $0.04
4/15/2020500 shares $24.15 -99.2%N/A0 $0.05
3/31/202061,000 shares $2,440.00 +634.9%N/A0.1 $0.04
3/13/20208,300 shares $498.00 +45.6%N/A0 $0.06
2/28/20205,700 shares $171.00 -79.2%N/A0 $0.03
2/14/202027,400 shares $1,096.00 +103.0%N/A0 $0.04
1/31/202013,500 shares $810.00 -2.2%N/A0 $0.06
1/15/202013,800 shares $924.60 -33.3%N/A0 $0.07
12/31/201920,700 shares $1,242.00 -95.9%N/A0 $0.06

PVCT Short Interest - Frequently Asked Questions

What is Provectus Biopharmaceuticals' current short interest?

Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 142,600 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest.

Is Provectus Biopharmaceuticals' short interest increasing or decreasing?

Provectus Biopharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 142,600 shares, an increase of 127.8% from the previous total of 62,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Provectus Biopharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Provectus Biopharmaceuticals: BioXcel Therapeutics, Inc. (4.00%), Cue Biopharma, Inc. (10.20%), Affimed (1.54%), SELLAS Life Sciences Group, Inc. (12.10%), Aclaris Therapeutics, Inc. (8.35%), vTv Therapeutics Inc. (3.18%), Sernova Corp. (0.00%), Assembly Biosciences, Inc. (0.68%), Spero Therapeutics, Inc. (0.87%), Rallybio Co. (9.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Provectus Biopharmaceuticals stock?

Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Provectus Biopharmaceuticals?

A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further.

How often is Provectus Biopharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:PVCT) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners